FTSE News: FTSE 100, FTSE 250, and FTSE 400 investment news
FTSE market news from the London Stock Exchange: FTSE 100, FTSE 250, and FTSE 400

Latest FTSE News:

  • Miners gain, house builders see declines

  • Oil, miners higher in London

  • Telecoms, retailers see gains

  • Pharma lower in London

  • British Energy drops on nuclear plant delays

  • Home builders see gains in London

  • House builders, property developers down in London

  • Brewers higher on bids rumors

  • Oil sector, banks mixed in London

  • BP, Royal Dutch Shell gain on higher oil prices

  • FTSE news feed

    Recommended equities news sites

  • Eurofirst News
  • Tokyo Market News
  • NYSE News
  • FTSE
  • London Stock Exchange
  •  

    April 7, 2006

    London markets decline

    Filed under: Companies, Royal Dutch Shell, BP, Kazakhmys, Rio Tinto, Antofagasta, Scottish & Southern Energy, British Energy, Shire, Barclay's, JKX Oil & Gas, Scottish Power

    The London equities markets were lower on Friday, but the FTSE 100 gained 1 percent over the week and managed to close out the week above the 6,000 level. The 100 was down 0.3 percent Friday to 6,026.1, while the FTSE 250 also lost 0.3 percent to 9,923.1.

    The oil sector saw gains on the day. BP added 1.3 percent to 681½p. Royal Dutch Shell was up 0.5 percent to £19.20. Among mid-caps, JKX Oil & Gas gained 10.4 percent to 352p. The gains came on a UBS upgrade of the sector from “neutral” to “overweight”.

    Energy stocks were down, however, again on remarks from UBS. Scottish & Southern Energy lost 2.3 percent to £11.30, while Scottish Power and British Energy were each down 1.7 percent, to 576p and 682p respectively.

    Miners gained on soaring metals prices. Kazakhmys added 11.3 percent during the week to £12.00. Antofagasta was up 5.4 percent to £22.35. Rio Tinto gained 4.9 percent to £30.65.

    Among banks, Barclays was up 2.2 percent on Friday to 701p on talk that Citigroup, newly freed by the US Federal Reserve of New York to make large deals, might be interested in bidding for the UK bank.

    Shire Pharmaceuticals was up 0.5 percent to 876½p after the US Food and Drug Administration approved its Daytrana patch for the treatment of attention deficit disorder.





    « Previous Page

    Latest Equities News:

  • Europe, US, most Asia markets lower on news, data

  • Equities decline globally on European debt concerns

  • Most global equities markets see declines on commodities prices

  • Europe, Asia markets mixed as Wall Street declines

  • European, US markets see gains as Asia markets remain mixed

  • European equities decline on lower credit rating for Greece

  • European equities markets gain, helped by US jobs report

  • Most global equities markets in decline

  • Europe, US, Asia markets all see declines

  • London markets see gains as most European markets retreat

  • FTSE News copyright 2012 Central Consultants